Roger Goldberg, MD, MBA
Show Description +
Roger Goldberg, MD, MBA, discusses the conversion to wet AMD in patients with GA treated with pegcetacoplan (Syfovre, Apellis) within the OAK, DERBY, and GAIL trials.
Posted: 8/08/2023
Roger Goldberg, MD, MBA
Roger Goldberg, MD, MBA, discusses the conversion to wet AMD in patients with GA treated with pegcetacoplan (Syfovre, Apellis) within the OAK, DERBY, and GAIL trials.
Posted: 8/08/2023
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2023.
Please log in to leave a comment.